Institutional Ownership
Arcus Biosciences Inc
CUSIP 03969F109COMRCUSQ1 2026
13D / 13G Filings
50
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
35.0%
Max % of class reported
Institutional Holders
203
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
50 filings · latest Jan 8, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 8, 2026 | Blackrock, Inc. | 13G/A | 10.4% | 12.74M | SEC |
| 2 | Nov 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 4.1% | 4.33M | SEC |
| 3 | Nov 5, 2025 | Gilead Sciences, Inc. | 13D/A | 25.6% | — | SEC |
| 4 | Jul 15, 2025 | Gilead Sciences, Inc. | 13D/A | 29.7% | — | SEC |
| 5 | May 13, 2025 | Point72 Asset Management, L.P. | 13G | 5.5% | 5.83M | SEC |
| 6 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 9.4% | 9.98M | SEC |
| 7 | Mar 5, 2025 | Gilead Sciences, Inc. | 13D/A | 35.0% | — | SEC |
| 8 | Feb 20, 2025 | Gilead Sciences, Inc. | 13D/A | 35.0% | — | SEC |
| 9 | Dec 17, 2024 | Rosen Terry J | 13D/A | 4.1% | 3.79M | SEC |
| 10 | Nov 12, 2024 | Fmr LLC | 13G/A | 4.9% | — | SEC |
40 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Arcus Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 31.42M | $678.77M |
| 2 | Blackrock, Inc. | 15.23M | $328.89M |
| 3 | Wellington Management Group LLP | 6.09M | $131.53M |
| 4 | State Street Corp | 5.41M | $116.92M |
| 5 | Suvretta Capital Management, LLC | 5.03M | $108.67M |
| 6 | Woodline Partners LP | 3.78M | $81.60M |
| 7 | Marshall Wace, LLP | 3.76M | $81.25M |
| 8 | Siren, L.L.C. | 3.01M | $64.95M |
| 9 | Geode Capital Management, LLC | 2.25M | $48.66M |
| 10 | Fisher Asset Management, LLC | 2.19M | $47.31M |